Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Autor: | Patorno, E., Pawar, A., Franklin, J.M., Najafzadeh, M., Déruaz-Luyet, A., Brodovicz, K.G., Sambevski, S., Bessette, L.G., Kulldorff, M., Schneeweiss, S. |
---|---|
Zdroj: | In Metabolism March 2020 104 Supplement |
Databáze: | ScienceDirect |
Externí odkaz: |